AbbVie (ABBV) reported a profit for third quarter that decreased from last year but beat the Street estimates.
The company's earnings totaled $1.561 billion, or $0.88 per share. This compares with $1.778 billion, or $1.00 per share, in last year's third quarter.
Excluding items, AbbVie reported adjusted earnings of $5.327 billion or $3.00 per share for the period.
Analysts on average had expected the company to earn $2.91 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 3.8% to $14.460 billion from $13.927 billion last year.
AbbVie earnings at a glance (GAAP) :
-Earnings (Q3): $1.561 Bln. vs. $1.778 Bln. last year.-EPS (Q3): $0.88 vs. $1.00 last year.-Revenue (Q3): $14.460 Bln vs. $13.927 Bln last year.
-Guidance:Full year EPS guidance: $10.90 - $10.94
For comments and feedback contact: editorial@rttnews.com
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.